×
AAs the biopharmaceutical sector continues to evolve, the demand for highly skilled biostatisticians with practical clinical development experience continues to grow. CP Analytics recognizes the importance of specialized, ongoing education that helps biostatisticians strengthen their technical capabilities and expand their knowledge of the pharmaceutical and biotechnology industries.
Beginning in 2027, CP Analytics plans to expand its services to include educational resources and professional development opportunities specifically designed for biostatisticians. These offerings will complement our biostatistics and statistical programming services and draw upon real-world experience supporting clinical research and development.
Our planned educational programs will focus on strengthening the skills needed to work effectively in clinical trials and the broader biopharmaceutical industry. Topics are expected to include clinical trial biostatistics, statistical analysis planning, statistical programming, CDISC standards, regulatory considerations, interpretation and communication of statistical results, and other practical skills used throughout clinical development.
Our goal is to help biostatisticians bridge the gap between statistical knowledge and its practical application within the pharmaceutical, biotechnology, and CRO environments.
Educational and professional development services are currently in development and are anticipated to become available in 2027.
Biostatisticians play a critical role throughout clinical development, from study design
and analysis through the interpretation and communication of clinical trial results.
At the same time, the statistical, regulatory, and technological landscape of clinical
research continues to evolve well beyond what can be covered during formal statistical
education.
Beginning in 2027, CP Analytics plans to offer a growing collection of educational
resources designed to help biostatisticians continue developing the knowledge and
practical skills needed throughout their careers. Planned resources include articles,
case studies, webinars, technical guides, and interactive learning tools covering topics
ranging from foundational clinical trial concepts to emerging statistical methods,
regulatory expectations, and developments in clinical research.
Our educational content will emphasize the practical application of statistical
principles within pharmaceutical, biotechnology, and CRO environments. Resources will
be developed with input from experienced industry professionals to promote both
technical rigor and real-world relevance.
CP Analytics also plans to introduce targeted professional training designed for
biostatisticians who want to strengthen or expand their clinical development expertise.
Programs will build upon existing statistical knowledge while emphasizing the practical
skills required to contribute effectively to clinical trial teams.
Planned training areas include clinical trial design and analysis, Statistical Analysis
Plan (SAP) development, statistical programming using SAS and R, CDISC standards,
regulatory considerations, interpretation of clinical trial results, and effective
communication of statistical findings with cross-functional teams.
More advanced educational offerings are expected to address areas such as survival
analysis, longitudinal data analysis, missing data, adaptive designs, real-world evidence,
pharmacokinetic analyses, and other statistical methodologies used across clinical
development.
Our objective is to provide practical, industry-focused education that helps
biostatisticians translate statistical knowledge into the skills required to work
successfully within pharmaceutical, biotechnology, CRO, and clinical research
organizations.
These educational and professional development programs are currently in development
and are anticipated to begin becoming available in 2027.
